For now, T-Mobile restricts the beta for SpaceX's direct-to-cell Starlink system to Samsung S24 phones and two Galaxy ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

Johnson & Johnson and Intra-Cellular Therapies, Inc. announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of ...